Shardul Amarchand Mangaldas: Manipal Health Enterprises IPO Legal Counsel

• Manipal Health Enterprises Limited completed an IPO valued at approximately 92,752.16 million (USD973.1 million), including a fresh issue and an offer for sale.
• The equity shares were listed on BSE Limited and the National Stock Exchange of India Limited on August 5, 2026.
• Shardul Amarchand Mangaldas & Co. acted as Indian legal counsel for Seventy Second Investment Company LLC, an affiliate of Mubadala Investment Company.
• SAM advised the Mubadala Selling Shareholder on all Indian law aspects, including the offer for sale and transaction documentation.
• A dedicated team from SAM, including partners Prashant Gupta, Manjari Tyagi, and Gouri Puri, led the capital markets and tax aspects of the deal.

This transaction underscores the growing maturity and appeal of the Indian capital markets for both domestic and international investors.

Manipal Health Enterprises Limited recently completed a significant initial public offering (IPO) of its equity shares, culminating in a total capital raise of approximately 92,752.16 million, which translates to roughly USD973.1 million. This substantial public offering was structured to include two distinct components: a fresh issuance of equity shares that generated 80,000.00 million, complemented by an offer for sale (OFS) from existing shareholders, which accounted for 12,752.16 million.

The successful listing of Manipal Health Enterprises Limited's equity shares occurred on August 5, 2026. The shares commenced trading on both of India's premier stock exchanges: BSE Limited and the National Stock Exchange of India Limited. This dual listing provides broad market access and visibility for the newly public entity.

For this landmark transaction, Shardul Amarchand Mangaldas & Co. (SAM) served as the Indian legal counsel to Seventy Second Investment Company LLC, an entity affiliated with Mubadala Investment Company. This affiliate was specifically identified as the Mubadala Selling Shareholder within the context of the IPO. SAM's mandate encompassed comprehensive advisory services on all facets of Indian law pertinent to the transaction.

The scope of SAM's engagement for the Mubadala Selling Shareholder was extensive, covering crucial areas such as the offer for sale component directly involving Mubadala. Furthermore, the firm was instrumental in the meticulous review, negotiation, and finalization of all transaction documentation, ensuring compliance and safeguarding the client's interests throughout the complex IPO process. The firm's involvement highlights the specialized expertise required for navigating large-scale capital market events in India.

The successful execution of the Manipal Health Enterprises IPO, particularly from the perspective of the Mubadala Selling Shareholder, was supported by a dedicated team from Shardul Amarchand Mangaldas & Co. The capital markets aspects of the transaction were spearheaded by Prashant Gupta, who serves as Partner and National Practice Head for Capital Markets, alongside Manjari Tyagi, a Partner at the firm. They were further supported by Jheel Bhargava, a Senior Associate, and Bhumika Panigrahi, an Associate.

Addressing the intricate tax implications of the IPO, the firm's tax team was led by Gouri Puri, a Partner, with significant contributions from Nimish Malpani, a Principal Associate. This multi-disciplinary approach underscores the comprehensive legal support necessary for major Indian capital markets IPO advice, ensuring all regulatory and financial aspects are meticulously managed for international investors like Mubadala.

The Manipal Health Enterprises listing in India represents a significant event within the nation's capital markets, not only due to its substantial value but also for the intricate legal and regulatory framework it navigated. Such large-scale offerings necessitate robust legal counsel, particularly when involving international investors like Mubadala, who require expert guidance on local laws and market practices. The transaction serves as a precedent for structuring similar major capital market deals, showcasing the capabilities of Indian legal firms in handling complex public offerings.

This transaction underscores the growing maturity and appeal of the Indian capital markets for both domestic and international investors. The involvement of experienced legal counsel, such as Shardul Amarchand Mangaldas, in advising key selling shareholders like the Mubadala affiliate, is crucial for ensuring smooth execution and compliance, thereby reinforcing confidence in the market's integrity and operational efficiency for future Manipal Health Enterprises IPO legal counsel engagements.

This transaction highlights the legal complexities and counsel involved in major Indian IPOs, offering a precedent for structuring similar large-scale capital market deals and identifying experienced firms for international investors.

Source: Original reporting via Bar & Bench